These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 20837722)

  • 1. Recognizing and managing a malignant hyperthermia crisis: guidelines from the European Malignant Hyperthermia Group.
    Glahn KP; Ellis FR; Halsall PJ; Müller CR; Snoeck MM; Urwyler A; Wappler F;
    Br J Anaesth; 2010 Oct; 105(4):417-20. PubMed ID: 20837722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Malignant hyperthermia: new developments in diagnosis and clinical management].
    Dépret T; Krivosic-Horber R
    Ann Fr Anesth Reanim; 2001 Dec; 20(10):838-52. PubMed ID: 11803844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Malignant Hyperthermia - Update on Pathophysiology, Diagnostics and Treatment].
    Johannsen S; Schuster F
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2019 Sep; 54(9):527-537. PubMed ID: 31525786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant hyperthermia, a Scandinavian update.
    Broman M; Islander G; Müller CR
    Acta Anaesthesiol Scand; 2015 Sep; 59(8):951-61. PubMed ID: 25989378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fulminant MH crisis during the ninth general anaesthesia].
    Adam H; Gottschaldt U; Pausch NC; Rüffert H; Sipli KM
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2007 Oct; 42(10):692-9. PubMed ID: 17968765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. This looks like malignant hyperthermia!
    Rivera PH; Worley C
    J Post Anesth Nurs; 1995 Oct; 10(5):265-73; QUIZ 273-6. PubMed ID: 8632363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant hyperthermia in Mazovia Province - are we adequately prepared?
    Cieniewicz A; Trzebicki J
    Anaesthesiol Intensive Ther; 2022; 54(2):99-102. PubMed ID: 35579281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of malignant hyperthermia crisis during anesthesia].
    Amiel I; Nivoche Y
    Ann Fr Anesth Reanim; 1989; 8(5):427-34. PubMed ID: 2697157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant Hyperthermia-Susceptible Adult Patient and Ambulatory Surgery Center: Society for Ambulatory Anesthesia and Ambulatory Surgical Care Committee of the American Society of Anesthesiologists Position Statement.
    Urman RD; Rajan N; Belani K; Gayer S; Joshi GP
    Anesth Analg; 2019 Aug; 129(2):347-349. PubMed ID: 31166228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How do anaesthesiologists treat malignant hyperthermia in a full-scale anaesthesia simulator?
    i Gardi T; Christensen UC; Jacobsen J; Jensen PF; Ording H
    Acta Anaesthesiol Scand; 2001 Sep; 45(8):1032-5. PubMed ID: 11576057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant hyperthermia deaths related to inadequate temperature monitoring, 2007-2012: a report from the North American malignant hyperthermia registry of the malignant hyperthermia association of the United States.
    Larach MG; Brandom BW; Allen GC; Gronert GA; Lehman EB
    Anesth Analg; 2014 Dec; 119(6):1359-66. PubMed ID: 25268394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant hyperthermia.
    Rosenberg H; Davis M; James D; Pollock N; Stowell K
    Orphanet J Rare Dis; 2007 Apr; 2():21. PubMed ID: 17456235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant hyperthermia.
    Taiclet L
    Anesth Prog; 1985; 32(4):140-2. PubMed ID: 3865561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed onset of malignant hyperthermia in the intensive care unit: a rare but life-threatening disorder.
    Twine N
    Crit Care Nurs Q; 2013; 36(2):213-7. PubMed ID: 23470706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant hyperthermia with excellent response to small dose of dantrolene.
    Chang KY; Ting CK; Chan KH; Tsai SK
    Acta Anaesthesiol Taiwan; 2004 Dec; 42(4):241-5. PubMed ID: 15679136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Availability of dantrolene for the management of malignant hyperthermia crises: European Malignant Hyperthermia Group guidelines.
    Glahn KPE; Bendixen D; Girard T; Hopkins PM; Johannsen S; Rüffert H; Snoeck MM; Urwyler A;
    Br J Anaesth; 2020 Aug; 125(2):133-140. PubMed ID: 32591088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Malignant hyperthermia--diagnostics, treatment and anaesthetic management].
    Schuster F; Müller-Reible CR
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Nov; 44(11-12):758-63; quiz 764. PubMed ID: 19918708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anaesthetic management of the malignant hyperthermia susceptible parturient.
    Douglas MJ; McMorland GH
    Can Anaesth Soc J; 1986 May; 33(3 Pt 1):371-8. PubMed ID: 3719439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant hyperthermia crisis: optimizing patient outcomes through simulation and interdisciplinary collaboration.
    Cain CL; Riess ML; Gettrust L; Novalija J
    AORN J; 2014 Feb; 99(2):301-8; quiz 309-11. PubMed ID: 24472592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is It Exertional Heatstroke or Something More? A Case Report.
    Reske-Nielsen C; Schlosser K; Pascucci RC; Feldman JA
    J Emerg Med; 2016 Aug; 51(2):e1-5. PubMed ID: 27041490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.